Skip to main content

Articles

Page 20 of 21

  1. Artemisinin-based combination therapy is increasingly being adopted as first-line antimalarial therapy. The choice of appropriate therapy depends on efficacy, cost, side effects, and simplicity of administration.

    Authors: Ishag Adam, Mamoun Magzoub, Maha E Osman, Insaf F Khalil, Michael Alifrangis and Khalid A Elmardi
    Citation: Annals of Clinical Microbiology and Antimicrobials 2006 5:18
  2. Aspergillus is a ubiquitous soil-dwelling fungus known to cause significant pulmonary infection in immunocompromised patients. The incidence of aspergillosis has increased during the past two decades and is a fre...

    Authors: Ridvan Ali, Fahir Ozkalemkas, Tulay Ozcelik, Vildan Ozkocaman, Atilla Ozkan, Sami Bayram, Beyza Ener, Ahmet Ursavas, Guze Ozal and Ahmet Tunali
    Citation: Annals of Clinical Microbiology and Antimicrobials 2006 5:17
  3. Methicillin-resistant Staphylococcus aureus (MRSA) has become increasingly prevalent worldwide since it was first reported in a British hospital. The prevalence however, varies markedly in hospitals in the same c...

    Authors: Patrick Eberechi Akpaka, Shivnarine Kissoon, William Henry Swanston and Michele Monteil
    Citation: Annals of Clinical Microbiology and Antimicrobials 2006 5:16
  4. Polymorphonuclear neutrophil granulocytes (PMN) are phagocytes of the first line of antimicrobial defense. Previously we demonstrated that lipoteichoic acid (LTA) from Staphylococcus aureus (S. aureus) directly a...

    Authors: Sonja Lotz, Andrea Starke, Christian Ziemann, Siegfried Morath, Thomas Hartung, Werner Solbach and Tamás Laskay
    Citation: Annals of Clinical Microbiology and Antimicrobials 2006 5:15
  5. Multi-drug resistant Pseudomonas aeruginosa nosocomial infections are increasingly recognized worldwide. In this study, we focused on the virulence of multi-drug resistant clinical strains P. aeruginosa against t...

    Authors: Olga Zaborina, Jonathan E Kohler, Yingmin Wang, Cindy Bethel, Olga Shevchenko, Licheng Wu, Jerrold R Turner and John C Alverdy
    Citation: Annals of Clinical Microbiology and Antimicrobials 2006 5:14
  6. The regular increase in the incidence of respiratory illness caused by respiratory syncytial virus (RSV) during winter months in the United Kingdom, and other countries with temperate climate is usually accomp...

    Authors: Nteimam Jonathan
    Citation: Annals of Clinical Microbiology and Antimicrobials 2006 5:13
  7. Conventional methods for susceptibility testing require several months before results can be reported. However, rapid methods to determine drug susceptibility have been developed recently. Phage assay have bee...

    Authors: Sergio Luis Yzquierdo, Dihadenys Lemus, Miguel Echemendia, Ernesto Montoro, Ruth McNerney, Anandi Martin and Juan Carlos Palomino
    Citation: Annals of Clinical Microbiology and Antimicrobials 2006 5:11
  8. Acinetobacter baumannii has emerged as a major nosocomial pathogen worldwide. Many of the circulating strains exhibit multi-drug resistance remaining consistently susceptible only to polymyxins. In-vitro studies ...

    Authors: David W Wareham and David C Bean
    Citation: Annals of Clinical Microbiology and Antimicrobials 2006 5:10
  9. The Hepatitis B virus (HBV) is a DNA virus that can cause both acute and chronic liver disease in humans. Approximately 350–400 million people are affected worldwide and up to one million deaths occur annually...

    Authors: Ian R Schreibman and Eugene R Schiff
    Citation: Annals of Clinical Microbiology and Antimicrobials 2006 5:8
  10. Ventilator associated pneumonia (VAP) is the leading cause of morbidity and mortality in intensive care units. The incidence of VAP varies from 7% to 70% in different studies and the mortality rates are 20–75%...

    Authors: Emine Alp and Andreas Voss
    Citation: Annals of Clinical Microbiology and Antimicrobials 2006 5:7
  11. CPD-associated peritonitis is a leading cause of morbidity and mortality for ESRD patients maintained on CPD therapy. The percentage of ESRD patients maintained on CPD therapy is declining. The reasons are unc...

    Authors: Laura Troidle and Fred Finkelstein
    Citation: Annals of Clinical Microbiology and Antimicrobials 2006 5:6
  12. Methicillin-resistant Staphylococcus aureus (MRSA) and coagulase-negative staphylococcus infections are a worldwide concern. Currently, these isolates have also shown resistance to vancomycin, the last therapy us...

    Authors: Eliezer Menezes Pereira, Thelma de Barros Machado, Ivana Correa Ramos Leal, Desyreé Murta Jesus, Clarissa Rosa de Almeida Damaso, Antonio Ventura Pinto, Marcia Giambiagi-deMarval, Ricardo Machado Kuster and Kátia Regina Netto dos Santos
    Citation: Annals of Clinical Microbiology and Antimicrobials 2006 5:5
  13. Vaginitis is among the most common conditions women are seeking medical care for. Although these infections can easily be treated, the relapse rate is high. This may be due to inadequate use of the diagnostic ...

    Authors: Andreas Schwiertz, David Taras, Kerstin Rusch and Volker Rusch
    Citation: Annals of Clinical Microbiology and Antimicrobials 2006 5:4
  14. Rifampicin, an important drug in the treatment of tuberculosis, is used extensively despite its broad effects on drug-drug interactions, creating serious problems. The clinical importance of such interactions ...

    Authors: Jiezhong Chen and Kenneth Raymond
    Citation: Annals of Clinical Microbiology and Antimicrobials 2006 5:3
  15. The virulence, antimicrobial resistance, and prevalence of S. aureus underscores the need for up-to-date and extensive insights regarding antimicrobial susceptibility trends. One approach to meet this need is ana...

    Authors: David Styers, Daniel J Sheehan, Patricia Hogan and Daniel F Sahm
    Citation: Annals of Clinical Microbiology and Antimicrobials 2006 5:2
  16. CHROMagar Candida (CaC) is increasingly being reported as a medium used to differentiate Candida albicans from non-albicans Candida (NAC) species. Rapid identification of NAC can assist the clinician in selecting...

    Authors: Duane R Hospenthal, Miriam L Beckius, Karon L Floyd, Lynn L Horvath and Clinton K Murray
    Citation: Annals of Clinical Microbiology and Antimicrobials 2006 5:1
  17. The presence of a Type III secretion system in clinical isolates of Pseudomonas aeruginosa is associated with severe disease and poor outcomes in infections caused by this pathogen. We describe an indirect enzyme...

    Authors: Li Li, Michel Ledizet, Kalipada Kar, Raymond A Koski and Barbara I Kazmierczak
    Citation: Annals of Clinical Microbiology and Antimicrobials 2005 4:22
  18. Penicillium sp., other than P. marneffei, is an unusual cause of invasive disease. These organisms are often identified in immunosuppressed patients, either due to human immunodeficiency virus or from immunosuppr...

    Authors: Adrian L Barcus, Steven D Burdette and Thomas E Herchline
    Citation: Annals of Clinical Microbiology and Antimicrobials 2005 4:21
  19. Eradication of Helicobacter pylori is an important objective in overcoming gastric diseases. Many regimens are currently available but none of them could achieve 100% success in eradication. Eugenol and cinnamald...

    Authors: Shaik Mahaboob Ali, Aleem A Khan, Irshad Ahmed, M Musaddiq, Khaja S Ahmed, H Polasa, L Venkateswar Rao, Chittoor M Habibullah, Leonardo A Sechi and Niyaz Ahmed
    Citation: Annals of Clinical Microbiology and Antimicrobials 2005 4:20
  20. Investigation of two independent outbreaks of post cataract surgery endophthalmitis identified the reservoir of epidemic strains of P. aeruginosa.

    Authors: Prashanth Kenchappa, Virender S Sangwan, Niyaz Ahmed, K Rajender Rao, Avinash Pathengay, Annie Mathai, Tarannum Mansoori, Taraprasad Das, Seyed E Hasnain and Savitri Sharma
    Citation: Annals of Clinical Microbiology and Antimicrobials 2005 4:19
  21. Anaplasma phagocytophilum causes human granulocytic anaplasmosis (HGA) in humans, which has been recognized as an emerging tick-borne disease in the United States and Europe. Although about 65 cases of HGA have b...

    Authors: J de la Fuente, A Torina, V Naranjo, S Caracappa, V Di Marco, A Alongi, M Russo, AR Maggio and KM Kocan
    Citation: Annals of Clinical Microbiology and Antimicrobials 2005 4:15
  22. Of the diverse presentation of neurobrucellosis, intra-medullary spinal cord abscess is extremely rare. Only four other cases have been reported so far. We present a case of spinal cord intra-medullary abscess...

    Authors: Girish V Vajramani, Mahantesh B Nagmoti and Chidanand S Patil
    Citation: Annals of Clinical Microbiology and Antimicrobials 2005 4:14
  23. The number of Salmonella strains with reduced susceptibility to fluoroquinolones has increased during recent years in many countries, threatening the value of this antimicrobial group in the treatment of severe s...

    Authors: Pirkko Kotilainen, Susa Pitkänen, Anja Siitonen, Pentti Huovinen and Antti J Hakanen
    Citation: Annals of Clinical Microbiology and Antimicrobials 2005 4:12
  24. CMV-induced vasculopathy and thrombosis have been reported, but they are rare conditions usually encountered in immunocompromised patients. However more and more complications of CMV infections are recognized ...

    Authors: Clarisse Rovery, Brigitte Granel, Philippe Parola, Cédric Foucault and Philippe Brouqui
    Citation: Annals of Clinical Microbiology and Antimicrobials 2005 4:11
  25. Leptospirosis is a zoonotic disease caused by the genus, Leptospira. Leptospira interrogans is the most common genomospecies implicated in the disease. Epidemiological investigations are needed to distinguish out...

    Authors: Andrew T Slack, Michael F Dohnt, Meegan L Symonds and Lee D Smythe
    Citation: Annals of Clinical Microbiology and Antimicrobials 2005 4:10
  26. Mutations in a small region of the rpoB gene are responsible for most rifamycin resistance in Mycobacterium tuberculosis. In this study we have sequentially generated resistant strains to first rifampicin and the...

    Authors: Richard M Anthony, Anja RJ Schuitema, Indra L Bergval, Tim J Brown, Linda Oskam and Paul R Klatser
    Citation: Annals of Clinical Microbiology and Antimicrobials 2005 4:9
  27. Toxigenic strains of Corynebacterium diphtheriae are well known agent of diphtheria. Nontoxigenic strains can cause atypical course of the disease. Invasive diseases caused by C. diphtheriae occur very rare.

    Authors: Aleksandra Anna Zasada, Maria Zaleska, Regina Beata Podlasin and Ilona Seferyńska
    Citation: Annals of Clinical Microbiology and Antimicrobials 2005 4:8
  28. Changes in morphology and growth curve of Candida albicans in response to treatment by Cisplatin has been studied using fluorescence staining with ethidium bromide. Treatment with Cisplatin was found to markedly ...

    Authors: Chandrasekhar Kesavan, Malathi Raghunathan and Natarajan Ganesan
    Citation: Annals of Clinical Microbiology and Antimicrobials 2005 4:7
  29. Latent tuberculosis infection (LTBI) is affecting one-third of the world population, and activation of LTBI is a substantial source of new cases of tuberculosis. LTBI is caused by tubercle bacilli in a state o...

    Authors: Leonid Heifets, Julie Simon and Van Pham
    Citation: Annals of Clinical Microbiology and Antimicrobials 2005 4:6
  30. Antimicrobial therapy is considered an important component in the medical management of most patients with acute exacerbation of chronic bronchitis (AECB). The three predominant bacterial species isolated are ...

    Authors: Sanjay Sethi, Antonio Anzueto and David J Farrell
    Citation: Annals of Clinical Microbiology and Antimicrobials 2005 4:5
  31. Chronic granulomatous disease (CGD) is a rare disorder of phagocytes in which absence of superoxide and hydrogen peroxide production in phagocytes predisposes patients to bacterial and fungal infections. The m...

    Authors: Setareh Mamishi, Kamiar Zomorodian, Farshid Saadat, Mohsen Gerami-Shoar, Bita Tarazooie and Seyad Ahmad Siadati
    Citation: Annals of Clinical Microbiology and Antimicrobials 2005 4:4
  32. In a retrospective study of HIV-infected patients, we investigated the influence of the MDR1 genotype (G2677T/A and C3435T) on the virological and immunological response of treatment naïve patients.

    Authors: Ralf Winzer, Peter Langmann, Michael Zilly, Franz Tollmann, Jörg Schubert, Hartwig Klinker and Benedikt Weissbrich
    Citation: Annals of Clinical Microbiology and Antimicrobials 2005 4:3
  33. Shed cells or disrupted parts of the biofilm may enter the circulation causing serious and very hard to treat biofilm-associated infections. The activity of antimicrobial agents against the shed cells/disrupte...

    Authors: Mohamed El-Azizi, Suma Rao, Termkiat Kanchanapoom and Nancy Khardori
    Citation: Annals of Clinical Microbiology and Antimicrobials 2005 4:2
  34. Amoebiasis is a major public health problem in tropical and subtropical countries. Although a number of antiamoebic agents are used for its treatment, yet the susceptibility data on clinical isolates of Entamoeba...

    Authors: Devendra Bansal, Rakesh Sehgal, Yogesh Chawla, Ramesh Chander Mahajan and Nancy Malla
    Citation: Annals of Clinical Microbiology and Antimicrobials 2004 3:27
  35. Patients with cystic fibrosis [CF] have frequent pulmonary exacerbations associated with the isolation of bacterial organisms from sputum samples. It is not clear however, if there are differences in the types...

    Authors: Terence E McManus, Andrew McDowell, John E Moore and Stuart J Elborn
    Citation: Annals of Clinical Microbiology and Antimicrobials 2004 3:26
  36. Helicobacter pylori diagnosis and susceptibility profile directs the applicability of recommended treatment regimens in our setting. To our knowledge, there is no published data on the culture and local susceptib...

    Authors: Raul V Destura, Eternity D Labio, Leah J Barrett, Cirle S Alcantara, Venancio I Gloria, Ma Lourdes O Daez and Richard L Guerrant
    Citation: Annals of Clinical Microbiology and Antimicrobials 2004 3:25
  37. Ampicillin was selected to further study the effect of this antibiotic on the colonization capability of S. pneumoniae and L. fermentum intranasally inoculated in a mice experimental model. The sensitivity of S. ...

    Authors: Rosa Cangemi de Gutiérrez, Viviana Santos, Marta Cecilia, Clara Silva and María Elena Nader-Macías
    Citation: Annals of Clinical Microbiology and Antimicrobials 2004 3:23
  38. Personal Digital Assistants (PDAS) are rapidly becoming popular tools in the assistance of managing hospitalized patients, but little is known about how often expert recommendations are available for the treat...

    Authors: Steven D Burdette, Thomas E Herchline and W Scott Richardson
    Citation: Annals of Clinical Microbiology and Antimicrobials 2004 3:22
  39. Pseudomonas aeruginosa (PA) is the most important bacterial pathogen in patients with cystic fibrosis (CF) patients. Currently, routine bacteriological culture on selective/non- selective culture media is the cor...

    Authors: Jiru Xu, John E Moore, Philip G Murphy, B Cherie Millar and J Stuart Elborn
    Citation: Annals of Clinical Microbiology and Antimicrobials 2004 3:21
  40. Emphysematous cystitis is a rare disease entity caused by gas fermenting bacterial and fungal pathogens. Clinical symptoms are nonspecific and diagnostic clues often arise from the unanticipated imaging findin...

    Authors: Ravi K Bobba, Edward L Arsura, Pawanjit S Sarna and Amar K Sawh
    Citation: Annals of Clinical Microbiology and Antimicrobials 2004 3:20
  41. Tuberculosis continues to be an important health problem in the world. Besides pulmonary involvement extrapulmonary involvement becomes an affair in developing countries, even in developed countries.

    Authors: Garip Sahin, Nuri Kiraz, Ilknur Sahin, Mehmet Soydan and Yurdanur Akgün
    Citation: Annals of Clinical Microbiology and Antimicrobials 2004 3:19
  42. Mycobacterium avium are ubiquitous environmental organisms and a cause of disseminated infection in patients with end-stage AIDS. The glycopeptidolipids (GPL) of M. avium are proposed to participate in the pathog...

    Authors: Vida R Irani, Sun-Hwa Lee, Torsten M Eckstein, Julia M Inamine, John T Belisle and Joel N Maslow
    Citation: Annals of Clinical Microbiology and Antimicrobials 2004 3:18